# Omega-3 Lipid Profile Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/omega-3-lipid-profile-meta-analysis-evidence-review
Category: evidence-review
Summary: Omega-3 Lipid Profile Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-08-15
Reviewed by: Migaku Evidence Review
# Omega-3 Lipid Profile Meta-analysis: What the Evidence Says

## Quick Answer

Omega-3 Lipid Profile Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials | systematic review | 1 | 2026-05-22 | 10.1002/edm2.70242 |
| Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients—Narrative Review | preclinical study | 4 | 2026-03-17 | 10.3390/nu18060939 |

## What The Sources Report

- This escalation is strongly associated with ageing populations, obesity, sedentary lifestyles, and improved survival of diabetic patients due to advances in early detection and therapeutic management. [Ghoflchi Sahar (2026); evidence level 1]
- By reducing curcumin to nanoscale particles, these formulations significantly enhance solubility, absorption and plasma retention, resulting in improved bioavailability and therapeutic efficacy. [Ghoflchi Sahar (2026); evidence level 1]
- Over time, however, increased rates of exaggerated inflammatory responses began to be reported in critically ill patients and in individuals receiving long-term parenteral nutrition, and excessive omega-6 fatty-acid delivery was considered a likely contributor to these adverse effects. [Kęska Mariusz (2026); evidence level 4]
- This article is a narrative review that aims to synthesize the mechanistic rationale and clinically relevant evidence regarding fish oil-containing injectable lipid emulsions (FO-ILE) used in parenteral nutrition (PN), with a focus on critically ill adult patients. [Kęska Mariusz (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For omega-3 lipid profile meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Ghoflchi Sahar (2026). Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. DOI: 10.1002/edm2.70242. PMCID: PMC13239566. PMID: 42171191. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13239566/
- Kęska Mariusz (2026). Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients—Narrative Review. DOI: 10.3390/nu18060939. PMCID: PMC13029142. PMID: 41901114. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13029142/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.